Showing results (201-210 of 351) with videos related to
Sort By:
Pageof 36
Journal of Gastroenterology|October 1, 2021
Effectiveness of tenofovir alafenamide for chronic hepatitis B patients with a poor response to the previously used nucleos(t)ide analogsDaiki Yamashige, Tetsuya Hosaka, Fumitaka Suzuki, et al.Internal Medicine (Tokyo, Japan)|March 28, 2022
Thrombotic Microangiopathy, Podocytopathy, and Damage to the Renal Tubules with Severe Proteinuria and Acute Renal Dysfunction Induced by LenvatinibSaki Nakashima, Akinari Sekine, Naoki Sawa, et al.Journal of Medical Virology|April 22, 2009
Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitusNorio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.Journal of Medical Virology|November 22, 2005
Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral loadNorio Akuta, Fumitaka Suzuki, Hitomi Sezaki, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 29, 2014
Therapeutic effects of short- and intermediate-term tolvaptan administration for refractory ascites in patients with advanced liver cirrhosisShintaro Akiyama, Kenji Ikeda, Hitomi Sezaki, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 2, 2005
Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameterKenji Ikeda, Masahiro Kobayashi, Satoshi Saitoh, et al.Journal of Medical Virology|December 2, 2009
Influence of amino-acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1bMariko Kobayashi, Norio Akuta, Fumitaka Suzuki, et al.Journal of Clinical Microbiology|June 21, 2013
Prediction of treatment efficacy and telaprevir-resistant variants after triple therapy in patients infected with hepatitis C virus genotype 1Norio Akuta, Fumitaka Suzuki, Taito Fukushima, et al.Gut and Liver|September 28, 2013
What Is the Most Effective Drug Delivery System for Cisplatin during the Treatment of Hepatic Tumors with Single-Session Transcatheter Chemotherapy? A Pilot StudyYusuke Kawamura, Kenji Ikeda, Taito Fukushima, et al.Oncology|February 23, 2016
Long-Term Outcomes of Hepatitis-C-Infected Patients Achieving a Sustained Virological Response and Undergoing Radical Treatment for Hepatocellular CarcinomaHideo Kunimoto, Kenji Ikeda, Yushi Sorin, et al.Pageof 36